3 ms·
Because having undetectable levels on day 1 doesn’t mean you have undetectable levels on day X and people don’t test every single day. Further, if you’re in a
by Retric 4y ago
Because having undetectable levels on day 1 doesn’t mean you have undetectable levels on day X and people don’t test every single day.
Further, if you’re in a long term relationship for years and your status changes you don’t want to suddenly have a big secret come out.
- jjtheblunt 4y agoThis is a perfect counterexample for the flawed logic of the argument put forth by another commenter above, which appears in marketing materials for drug companies in American media, frighteningly.
- chimeracoder 4y ago> Because having undetectable levels on day 1 doesn’t mean you have undetectable levels on day X and people don’t test every single day. This is both clinically wrong and a red herring. Once a person has durably achieved clinical undetectability under HAART, they do remain undetectable.
- Retric 4y ago> they do remain undetectable False. https://pubmed.ncbi.nlm.nih.gov/19043927/ https://pubmed.ncbi.nlm.nih.gov/19043927/ In the first year after achieving VL undetectability, 354/1386 (25.5%) patients experienced low-level VL rebound, the remaining patients maintained consistent undetectability. Low-level rebound occurred less commonly with non-nucleoside reverse transcriptase inhibitor (NNRTI)-based HAART than with other regimens (P = 0.01). Over median 2.2 (range 0.0-7.4) years of subsequent follow-up, 86 (6.2%) patients experienced virological failure, corresponding to 2.30 failures per 100 person-years (95% confidence interval [CI] 1.82-2.79). Independent predictors of virological failure included low-level rebound during the first year after achieving undetectability relative to consistent undetectability (rate ratio [RR] 2.18, 95%0 CI 1.15-4.10), female gender (RR 1.79, 95% CI 1.12-2.85) and receiving a ritonavir-boosted protease inhibitor (Pl/r) relative to NNRTI-based HAART (RR 1.88, 95% CI 1.02-3.46).
- chimeracoder 4y ago> False. https://pubmed.ncbi.nlm.nih.gov/19043927/ https://pubmed.ncbi.nlm.nih.gov/19043927/ > In the first year after achieving VL undetectability... I'm gathering from your comments that you don't have a clinical background in HIV research (because if you did, you would not be posting this as a reply). Not only does your link not prove what you think it does, but it actually says the exact opposite: once a patient has durably achieved clinical undetectability under HAART, they do remain undetectable, even when using older generations of drugs that are no longer first-line treatments. It even states that in the conclusion: " Patients on first-line HAART who maintain consistent VL undetectability for 1 year have a low risk of subsequent virological failure." To spell it out: the mistake you're making is that you're looking at a paper that studies treatment-naive patients and whether or not they durably achieve undetectability, whereas what we're talking about is patients who have already durably achieved undetectability. So the paper you linked isn't particularly relevant to our conversation, because it's studying a completely unrelated endpoint, but by coincidence, it does actually corroborate the point I was making.
- Retric 4y agoWhat you quoted does not support your point. “have a low risk of subsequent virological failure" Low risk is not zero risk. Also the actual population of people who durably achieved undetectability is effectively a true Scotsman argument in that you reject people who seemed to achieve it who then became detectable again. We don’t have long term data saying all people who are undetectable for N years are undetectable for 40 years because the treatments aren’t that old. All we can do is extrapolate and people who are undetectable for even 4 years have become detectable. Newer treatments look promising but they have even less long term data to extrapolate from. And of course things look even worse when people stop taking treatment for various reasons.
- elil17 4y agoDurable viral undetectability means someone has remained undetectable across all viral load measurements for 12 continuous months. So, no, it’s not a “no true Scotsman argument.” This is a scientific term with a specific definition.